Suture Market Size, Share, Growth, and Industry Analysis, By Type (Absorbable Sutures,Non-absorbable Sutures), By Application (Human Application,Veterinary Application), Regional Insights and Forecast to 2035

Suture Market Overview

The global Suture Market size is projected to grow from USD 1292.372918 million in 2026 to USD 1370.7 million in 2027, reaching USD 2194.5852388395 million by 2035, expanding at a CAGR of 6.06% during the forecast period.

The global suture market is heavily influenced by surgical procedure volumes, which exceed 300 million annually worldwide. In 2023, absorbable sutures accounted for about 55.5 percent of total demand, while non-absorbable sutures made up the rest. Multifilament products represented nearly 59 percent of filament type use globally. General surgery applications represented 26.8 percent of usage, while acute wound management contributed around 71.5 percent. Hospitals and clinics formed the largest end-use category with a 53.9 percent share in 2024. North America alone represented nearly 39.3 percent of global market share, followed by Europe and Asia-Pacific.

The United States dominated the North American suture market with nearly 77.1 percent of the region’s total share in 2024. Absorbable sutures accounted for more than 55 percent of U.S. usage, with synthetic absorbable threads showing strong growth. Multifilament sutures accounted for about 59 percent of filament usage, particularly in cardiovascular and orthopedic surgeries. Acute wound treatments such as trauma cases accounted for 71.5 percent of suture usage nationally in 2024. General surgery made up 26.8 percent of application demand. Hospitals and clinics remained the key buyers, accounting for over 53 percent of consumption in the country.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Over 55 percent of demand is created by absorbable sutures, with acute wounds representing 71.5 percent of applications.
• Major Market Restraint: Non-absorbable sutures represent under 45 percent of demand, with cost-sensitive buyers delaying adoption in about 30 percent of low-income regions.
• Emerging Trends: Multifilament sutures account for nearly 59 percent of usage, and synthetic absorbables appear in more than 60 percent of new launches.
• Regional Leadership: North America accounts for 39.3 percent share, Asia-Pacific 18.4 percent, Europe 25 percent, and Middle East & Africa under 10 percent.
• Competitive Landscape: Johnson & Johnson and B. Braun dominate, with needled sterilized absorbables making up 80.9 percent of absorbable product value.
• Market Segmentation: Absorbable sutures hold 55.5 percent, non-absorbable 44.5 percent; hospitals and clinics contribute 53.9 percent, acute wounds 71.5 percent.
• Recent Development: Asia-Pacific absorbables represented 60.3 percent of share in 2023, while North America captured 39.3 percent in 2024 with rapid innovation.

Suture Market Latest Trends

The suture market has moved rapidly toward absorbable and synthetic materials. Absorbable sutures represented 55.5 percent of market share in 2023, while non-absorbables remained at 44.5 percent. Hospitals and clinics accounted for 53.9 percent of demand in 2024, showing that institutional healthcare remains the dominant end-use segment. Multifilament sutures are gaining preference, with 59 percent share, as surgeons prioritize knot security. Acute wound management drove 71.5 percent of demand globally in 2024, reflecting the growing need for trauma care solutions.

Suture Market Dynamics

DRIVER

"Rising global surgical volumes due to aging populations and increasing chronic diseases".

More than 300 million surgical procedures occur annually, with general surgery representing 26.8 percent of usage and acute wounds requiring sutures in 71.5 percent of cases in 2024. The elderly population in North America and Europe exceeds 16 percent of total demographics, raising demand for cardiovascular and orthopedic procedures. Hospitals and clinics contributed 53.9 percent of end-use globally, showing their dominance in purchasing high-quality absorbables. In 2024, synthetic absorbables held 55.5 percent share, with needled sterilized versions forming 80.9 percent of absorbable value. Multifilament sutures held 59 percent share, providing secure closures in trauma and cardiovascular operations.

RESTRAINT

"Cost and availability of alternatives limit wider adoption."

Non-absorbable sutures accounted for 44.5 percent of usage, but are less favored in minor surgeries due to removal requirements. Antimicrobial-coated sutures, which reduce infection rates by 20 percent, carry price premiums of 20–40 percent. Alternatives such as staples and adhesives now cover 10–20 percent of wound closure needs, reducing suture usage in certain procedures. Regulatory hurdles delay product launches in Asia-Pacific and Africa, where approval processes can extend 12–24 months. Smaller clinics often select low-cost non-coated sutures, limiting penetration of premium products.

OPPORTUNITY

"Innovation in coated sutures and growth in emerging markets."

Asia-Pacific accounted for 18.4 percent of global share in 2023, with absorbables representing 60.3 percent of regional usage. Latin America and Middle East & Africa remain under-penetrated, with regional shares under 15 percent combined, creating opportunities for expansion. Outpatient surgical centers are increasing demand, representing a growing portion beyond hospitals’ 53.9 percent share. Development of barbed and knotless sutures provides surgeons with new techniques, already representing nearly 20 percent of new products in 2025. Antimicrobial and bioresorbable coated products are present in 25 percent of launches, showing opportunities for suppliers.

CHALLENGE

"Procurement pressure, supply chain delays, and standardization issues."

Raw material costs for polymers and antimicrobial coatings rose by 15–20 percent since 2022, limiting profitability. Multifilament sutures, with 59 percent share, require strict production control, raising manufacturing costs. Hospitals often negotiate aggressively, keeping margins thin, while new entrants struggle against established brands. Supply chain disruptions extended lead times for advanced sutures from 8–12 weeks to 16–24 weeks. Regulatory fragmentation requires different compliance standards across USA, EU, and Asia, complicating global distribution. Alternatives like adhesives, staples, and minimally invasive procedures further challenge suture demand in specific segments.

Suture Market Segmentation

The suture market is segmented by type and application. By type, absorbables accounted for 55.5 percent of share in 2023, non-absorbables for 44.5 percent. By application, human surgeries dominate, while veterinary applications contribute less than 20 percent globally. Hospitals and clinics represent 53.9 percent of end-use, while general surgery accounted for 26.8 percent of application demand.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Absorbable Sutures: Absorbable sutures made up 55.5% of the market in 2023, with synthetic variants dominating global usage. Needled sterilized absorbables contributed 80.9% of absorbable value in 2024. Hospitals and clinics, which represent 53.9% of end-use, favor them for acute wounds, accounting for 71.5% of demand.

Absorbable sutures are valued at USD 731.12 million in 2025 with a 60% share, forecasted to hit USD 1171.71 million by 2034, recording a CAGR of 6.04%, driven by high usage in general and cosmetic surgeries.

Top 5 Major Dominant Countries in the Absorbable Sutures Segment

• United States: Estimated USD 204.71 million in 2025 with 28% share, projected to grow to USD 328.05 million by 2034 at 6.05% CAGR, fueled by orthopedic and cardiovascular surgeries.
• Germany: USD 95.04 million in 2025 with 13% share, reaching USD 152.18 million by 2034 at 6.06% CAGR, supported by increasing minimally invasive procedures.
• China: USD 160.85 million in 2025 with 22% share, expected at USD 257.82 million by 2034 at 6.04% CAGR, led by expanding surgical infrastructure.
• Japan: USD 87.73 million in 2025 with 12% share, forecasted at USD 140.75 million by 2034 at 6.06% CAGR, driven by rising hospital surgeries.
• India: USD 73.11 million in 2025 with 10% share, projected at USD 117.17 million by 2034 at 6.04% CAGR, fueled by higher surgical admissions.

Non-Absorbable Sutures: Non-absorbables held 44.5% share in 2023, widely used in orthopedic, dermatology, and cardiovascular procedures. Materials such as nylon, silk, and polypropylene dominate. Multifilament designs are chosen for knot security, while monofilaments are selected in vascular cases requiring lower infection risk.

Non-absorbable sutures are projected at USD 487.41 million in 2025 with a 40% share, expected to reach USD 779.83 million by 2034, expanding at a CAGR of 6.09%, primarily in trauma and long-term surgical treatments.

Top 5 Major Dominant Countries in the Non-absorbable Sutures Segment

• United States: USD 141.35 million in 2025 with 29% share, anticipated at USD 226.15 million by 2034 at 6.10% CAGR, backed by trauma centers and chronic wound treatments.
• France: USD 77.98 million in 2025 with 16% share, projected at USD 124.74 million by 2034 at 6.08% CAGR, supported by cardiac and orthopedic procedures.
• China: USD 126.72 million in 2025 with 26% share, forecasted at USD 202.23 million by 2034 at 6.09% CAGR, led by hospital expansion.
• Japan: USD 68.24 million in 2025 with 14% share, estimated at USD 108.94 million by 2034 at 6.07% CAGR, supported by high surgical demand.
• India: USD 48.74 million in 2025 with 10% share, projected at USD 78.01 million by 2034 at 6.08% CAGR, driven by emergency surgical procedures.

BY APPLICATION

Human Application: Human surgeries accounted for more than 80% of global demand. General surgery contributed 26.8% of applications in 2024, with acute wounds driving 71.5% of usage. Hospitals and clinics remained the largest buyers, making up 53.9% of the market.

Human application is forecasted at USD 1096.68 million in 2025 with a 90% share, projected to hit USD 1756.38 million by 2034, reflecting a CAGR of 6.05% as hospitals continue leading in wound closure demand.

Top 5 Major Dominant Countries in Human Application

• United States: USD 285.14 million in 2025 with 26% share, projected at USD 456.66 million by 2034 at 6.07% CAGR, driven by cardiovascular and general surgeries.
• Germany: USD 131.60 million in 2025 with 12% share, reaching USD 210.83 million by 2034 at 6.06% CAGR, supported by high per capita surgical rates.
• China: USD 219.34 million in 2025 with 20% share, forecasted at USD 351.27 million by 2034 at 6.05% CAGR, propelled by public health expansion.
• Japan: USD 120.64 million in 2025 with 11% share, projected at USD 193.06 million by 2034 at 6.04% CAGR, driven by aging population surgeries.
• India: USD 109.67 million in 2025 with 10% share, expected at USD 175.64 million by 2034 at 6.05% CAGR, supported by growing surgical admissions.

Veterinary Application: Veterinary uses represented under 20% of global demand. Absorbables are preferred for internal procedures, while non-absorbables remain common for skin closures. Growth is visible in Asia-Pacific and Latin America, where rising pet ownership and livestock care increase consumption.

Veterinary application is valued at USD 121.85 million in 2025 with a 10% share, expected to reach USD 195.16 million by 2034, advancing at a CAGR of 6.07%, led by rising pet surgeries and livestock treatment.

Top 5 Major Dominant Countries in Veterinary Application

• United States: USD 36.56 million in 2025 with 30% share, projected at USD 58.55 million by 2034 at 6.08% CAGR, led by high veterinary care expenditure.
• United Kingdom: USD 14.62 million in 2025 with 12% share, forecasted at USD 23.43 million by 2034 at 6.07% CAGR, driven by pet surgical procedures.
• China: USD 18.28 million in 2025 with 15% share, projected at USD 29.29 million by 2034 at 6.06% CAGR, supported by livestock treatment growth.
• Germany: USD 12.18 million in 2025 with 10% share, expected at USD 19.51 million by 2034 at 6.06% CAGR, fueled by veterinary hospitals.
• Australia: USD 9.74 million in 2025 with 8% share, forecasted at USD 15.61 million by 2034 at 6.05% CAGR, driven by pet adoption surgeries.

Suture Market Regional Outlook

North America led with 39.3% share in 2024, with the USA contributing 77.1% of the region’s total and hospitals accounting for most of the 53.9% global end-use. Europe followed with around 25% share, supported by strict CE regulations and 30% of new launches featuring antimicrobial coatings. Asia-Pacific held 18.4% share in 2023, where absorbables made up 60.3% of usage and multifilaments dominated at 59%. Middle East & Africa remained below 10%, driven by Gulf countries’ hospital projects, with absorbables exceeding 50% but strong reliance on non-absorbables in trauma care.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America led the global market with 39.3 percent share in 2024. The USA contributed 77.1 percent of the regional total. Hospitals and clinics are primary end-users, with 53.9 percent share globally and higher proportions in North America. Absorbables exceeded 55 percent of type demand, supported by synthetic materials and needled sterilized variants, which represented 80.9 percent of absorbable value. Multifilament sutures accounted for 59 percent of regional use. General surgery contributed 26.8 percent, with acute wounds at 71.5 percent of cases. Antimicrobial and barbed sutures appeared in over 20 percent of new U.S. product launches.

North America market is projected at USD 450.86 million in 2025 with a 37% share, forecasted to reach USD 722.07 million by 2034 at 6.07% CAGR, driven by high surgical procedure rates and strong hospital infrastructure.

North America - Major Dominant Countries in the Suture Market Market

• United States: USD 355.18 million in 2025 with 78.8% share, expected at USD 568.54 million by 2034 at 6.07% CAGR, fueled by advanced healthcare networks.
• Canada: USD 54.10 million in 2025 with 12% share, projected at USD 86.59 million by 2034 at 6.06% CAGR, led by growing surgical demand.
• Mexico: USD 27.05 million in 2025 with 6% share, reaching USD 43.30 million by 2034 at 6.08% CAGR, supported by rising surgical admissions.
• Cuba: USD 7.66 million in 2025 with 1.7% share, forecasted at USD 12.27 million by 2034 at 6.07% CAGR, driven by hospital upgrades.
• Puerto Rico: USD 6.87 million in 2025 with 1.5% share, expected at USD 11.37 million by 2034 at 6.06% CAGR, supported by surgical expansions.

EUROPE

Europe accounted for about 25 percent of the global market in 2023–2024. Germany, France, Italy, and Spain were key producers and consumers. Hospitals and clinics drove end-use, consistent with the global 53.9 percent share. Absorbables held 55 percent regionally, while multifilaments maintained near 59 percent. Regulations required CE-marked sterilized sutures, slowing approval processes but ensuring quality. Acute wounds represented about 70 percent of usage in 2024. Adoption of antimicrobial-coated sutures expanded, with over 30 percent of launches in 2025 featuring coatings. Outpatient surgical centers also contributed to growing demand in Europe.

Europe market size is USD 341.19 million in 2025 with a 28% share, estimated at USD 546.44 million by 2034 at a CAGR of 6.06%, driven by robust hospital infrastructure and surgical specialization.

Europe - Major Dominant Countries in the Suture Market Market

• Germany: USD 115.99 million in 2025 with 34% share, projected at USD 185.18 million by 2034 at 6.05% CAGR, driven by advanced surgical systems.
• United Kingdom: USD 88.71 million in 2025 with 26% share, forecasted at USD 141.52 million by 2034 at 6.06% CAGR, led by surgical interventions.
• France: USD 61.41 million in 2025 with 18% share, expected at USD 97.90 million by 2034 at 6.06% CAGR, supported by hospital procedures.
• Italy: USD 47.77 million in 2025 with 14% share, reaching USD 76.21 million by 2034 at 6.07% CAGR, driven by cardiovascular surgeries.
• Spain: USD 27.30 million in 2025 with 8% share, forecasted at USD 43.63 million by 2034 at 6.06% CAGR, propelled by hospital infrastructure.

ASIA-PACIFIC

Asia-Pacific accounted for 18.4 percent of the global market in 2023. Absorbables dominated the region with 60.3 percent of type share in 2023, higher than the global average. China, India, and Japan were the largest contributors, with high surgical volumes in urban hospitals. Multifilament sutures dominated with 59 percent share, particularly in trauma and cardiovascular procedures. Hospitals and clinics were the main end-users, consistent with the global 53.9 percent benchmark. Acute wounds represented more than 70 percent of usage. Regulatory delays remain a restraint, but growing investment in healthcare infrastructure is expanding opportunities.

Asia market is valued at USD 329.00 million in 2025 with 27% share, projected at USD 526.91 million by 2034 at 6.07% CAGR, fueled by surgical demand in fast-growing healthcare systems.

Asia - Major Dominant Countries in the Suture Market Market

• China: USD 170.99 million in 2025 with 52% share, estimated at USD 273.85 million by 2034 at 6.06% CAGR, supported by expanding hospitals.
• India: USD 78.96 million in 2025 with 24% share, forecasted at USD 126.47 million by 2034 at 6.07% CAGR, driven by rising surgical admissions.
• Japan: USD 54.09 million in 2025 with 16% share, projected at USD 86.63 million by 2034 at 6.06% CAGR, fueled by aging population surgeries.
• South Korea: USD 16.45 million in 2025 with 5% share, expected at USD 26.32 million by 2034 at 6.07% CAGR, driven by cosmetic surgeries.
• Indonesia: USD 8.51 million in 2025 with 2.6% share, forecasted at USD 13.64 million by 2034 at 6.06% CAGR, supported by healthcare expansion.

MIDDLE EAST & AFRICA

The Middle East and Africa held less than 10 percent of global market share in 2023–2024. Gulf countries such as Saudi Arabia and UAE accounted for the majority of regional demand. Hospitals drove adoption, aligned with the global 53.9 percent end-use. Absorbables represented more than 50 percent of usage, but non-absorbables remained critical in trauma and dermatology. Multifilament sutures were preferred for knot security. Acute wounds dominated applications, similar to the global 71.5 percent level. Challenges included limited supply chains and high costs, but growing investment in hospital infrastructure increased procurement volumes.

Middle East and Africa market size is USD 97.48 million in 2025 with 8% share, expected to hit USD 156.13 million by 2034 at 6.07% CAGR, driven by expanding hospital services and surgical admissions.

Middle East and Africa - Major Dominant Countries in the Suture Market Market

• Saudi Arabia: USD 29.24 million in 2025 with 30% share, projected at USD 46.79 million by 2034 at 6.07% CAGR, fueled by hospital expansions.
• UAE: USD 21.45 million in 2025 with 22% share, forecasted at USD 34.32 million by 2034 at 6.06% CAGR, supported by growing surgical demand.
• South Africa: USD 16.57 million in 2025 with 17% share, expected at USD 26.53 million by 2034 at 6.07% CAGR, led by trauma and emergency cases.
• Egypt: USD 14.62 million in 2025 with 15% share, projected at USD 23.42 million by 2034 at 6.06% CAGR, driven by surgical procedures.
• Nigeria: USD 8.60 million in 2025 with 9% share, reaching USD 13.78 million by 2034 at 6.07% CAGR, fueled by growing healthcare demand.

List of Top Suture Companies

• DemeTech
• Assut Medical Sarl
• Usiol
• B.Braun
• CONMED
• Surgical Specialties Corporation
• Huaiyin Micra
• Johnson and Johnson Medical
• W.L. Gore and Associates
• Dolphin
• Jiangxi Longteng
• Kono Seisakusho
• Unik Surgical Sutures MFG
• Teleflex
• Nantong Huaerkang Medical Technology

Top two companies with highest market share:

• Johnson & Johnson Medical: Leading global manufacturer, strong in absorbable sutures, with high market share in North America.
• B.Braun: Significant share in Europe and global operations, strong across both absorbable and non-absorbable product lines.

Investment Analysis and Opportunities

Investment opportunities in the suture market are led by synthetic absorbables, which held 55.5 percent of type share in 2023. Needled sterilized absorbables represented 80.9 percent of absorbable value, showing the importance of ready-to-use products. Emerging markets present strong opportunities, with Asia-Pacific accounting for 18.4 percent of share in 2023 but having underdeveloped rural healthcare systems. Veterinary sutures, though less than 20 percent of total, are growing as pet care expands in Asia and Latin America.

New Product Development

Between 2023 and 2025, product innovation has focused on absorbables, barbed sutures, and antimicrobial coatings. Absorbables held 55.5 percent of type share in 2023, with synthetic variants improving tensile strength. New barbed sutures accounted for about 20 percent of launches, reducing knot-tying times by 30 percent in some procedures. Antimicrobial-coated sutures accounted for 25 percent of new launches in 2024, offering infection reduction benefits. Multifilament sutures remained dominant at 59 percent, but monofilament introductions made up 25–30 percent of new products.

Five Recent Developments

• Absorbable sutures accounted for 60.3 percent of Asia-Pacific demand in 2023, highlighting regional adoption.
• Multifilament sutures represented 59 percent of global use in 2023, driving capacity expansions.
• Acute wound closure drove 71.5 percent of global usage in 2024, raising production of trauma-specific suture kits.
• Needled sterilized absorbables accounted for 80.9 percent of absorbable revenue in 2024, expanding global supply chains.
• Antimicrobial-coated sutures reached 25 percent of new product launches in 2025, signaling increased focus on infection prevention.

Report Coverage

The Suture Market Market Report covers product segmentation including absorbable versus non-absorbable sutures, monofilament versus multifilament structures, and applications across human and veterinary surgery. It reviews global surgery volumes exceeding 300 million annually and their influence on demand. Market data includes absorbable sutures holding 55.5 percent of share in 2023, non-absorbables 44.5 percent, multifilament 59 percent, general surgery 26.8 percent, acute wounds 71.5 percent, and hospitals/clinics 53.9 percent of end-use.

Suture Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1292.372918 Million in 2026
Market Size Value By	USD 2194.5852388395 Million by 2035
Growth Rate	CAGR of 6.06% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Absorbable Sutures Non-absorbable Sutures By Application : Human Application Veterinary Application
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample